Esperion Therapeutics, Inc.ESPRNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, slight contraction.
Left:
||||
Free cash flow yield
Latest
-5.82%
↑ 83% above average
Average (9y)
-33.80%
Historical baseline
Range
High:-4.41%
Low:-182.55%
CAGR
-3.3%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -5.82% | +86.8% |
| 2023 | -43.95% | -4.0% |
| 2022 | -42.26% | +76.9% |
| 2021 | -182.55% | -1223.2% |
| 2020 | -13.80% | -212.6% |
| 2019 | -4.41% | +63.5% |
| 2018 | -12.09% | -45.1% |
| 2017 | -8.33% | +50.8% |
| 2016 | -16.94% | -115.8% |
| 2015 | -7.85% | - |